Huntington National Bank’s Insys Therapeutics, Inc. INSY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 4314 |
|
|
2025
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 4281 |
|
|
2025
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 4243 |
|
|
2025
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 4273 |
|
|
2025
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 4305 |
|
|
2024
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 4279 |
|
|
2024
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 4265 |
|
|
2024
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 4194 |
|
|
2024
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 4062 |
|
|
2023
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 4007 |
|
|
2023
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 3951 |
|
|
2023
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 3863 |
|
|
2023
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 3697 |
|
|
2022
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 3622 |
|
|
2022
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 2619 |
|
|
2022
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 2623 |
|
|
2022
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 2549 |
|
|
2021
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 2477 |
|
|
2021
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 2203 |
|
|
2021
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 2092 |
|
|
2021
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 1982 |
|
|
2020
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 1959 |
|
|
2020
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 1904 |
|
|
2020
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 1918 |
|
|
2020
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 2012 |
|
|
2019
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 2025 |
|
|
2019
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 1930 |
|
|
2019
Q2 | $0 | Buy |
+1
| New | +$3 | ﹤0.01% | 1958 |
|
|
2019
Q1 | – | Sell |
-1
| Closed | – | – | 1949 |
|
|
2018
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 2007 |
|
|
2018
Q3 | $0 | Buy |
+1
| New | +$8 | ﹤0.01% | 2000 |
|
Huntington National Bank's INSY Position: Q1 2026 in Review
Huntington National Bank held its Insys Therapeutics, Inc. (INSY) position steady in Q1 2026 at 1 share worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #4314.
Huntington National Bank first reported a position in INSY in Q3 2018 and has held it in 30 quarters since. 1 fund tracked by Wall St. Rank holds INSY as of Q1 2026.
- Huntington National Bank held 1 share of Insys Therapeutics, Inc. worth $0 as of Q1 2026.
- Huntington National Bank left its Insys Therapeutics, Inc. share count unchanged in Q1 2026.
- Insys Therapeutics, Inc. made up ﹤0.01% of Huntington National Bank's portfolio in Q1 2026, its #4314 holding.
- Huntington National Bank first reported a position in Insys Therapeutics, Inc. in Q3 2018 and has held it in 30 quarters since.
- 1 fund tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q1 2026.
Based on Huntington National Bank's 13F filing for Q1 2026, filed 15 May 2026.